FDA warned against Trump’s suggested Anti-malaria drug due to Heart issues

FDA warned against Trump’s suggested Anti-malaria drug due to Heart issues
Listen to this article

The FDA (Food and Drug Administration) has issued warnings against the use of Anti-malaria drugs (suggested by President Donald Trump) to treat coronavirus patients after heart problem reports. Point to be noted that the drugs hydroxychloroquine and chloroquine are often taken in combination to treat malaria. The drug was approved by President Trump on many occasions and labeled as a potential game-changer in treating Covid-19. Moreover, the FDA also warned against the use of drugs outside of a clinically monitored setting. The agency cited that they appear to cause abnormal heart rhythms. The agency said, “Hydroxychloroquine and chloroquine have not been shown to be safe and effective for treating or preventing Covid-19.”

FDA warned against Trump’s suggested Anti-malaria drug due to Heart issues

The agency also said, “These drugs can generate abnormal heart rhythms such as QT interval prolongation and a dangerously rapid heart rate called ventricular tachycardia. These risks may increase when these medicines are combined with other medicines, including azithromycin”. It is noteworthy that the medication is often used for use in malaria patients and to prevent people from living with lupus. Trump has formerly suggested the use of drugs as a potential treatment for the coronavirus in a number of his press conferences and on his social media. President earlier said, “I want them to try it, and it may work, and it may not work. But if it doesn’t work, there is nothing lost by doing it. What do you have to lose?”

Moreover, Trump appeared to stop pushing it publicly after the drug showed no benefit in a large analysis of its use in US Veterans hospitals. The study hasn’t undergone the typical peer-review process, as with many that have been undertaken during the pandemic. Medical experts continue to insist there is no concrete scientific evidence of the drug’s effectiveness or safety when used against coronavirus. The president of the American Medical Association, Dr. Patrice Harris said, “There could be deaths. This is a new virus, and so we should not be promoting any medication or drug for any disease that has not been proven and approved by the FDA.”